Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitiglinide + Metformin in Type 2 Diabetes Mellitus
NCT00519142Phase 3Completed
- Sponsor
- Elixir Pharmaceuticals
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by Elixir Pharmaceuticals. Started Aug 2007; status: completed.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00519142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519142.